New scan could give cancer patients faster answers
NCT ID NCT05957042
Summary
This study aimed to test if a special type of ultrasound scan, called contrast-enhanced ultrasound (CEUS), could tell doctors whether a patient's triple-negative breast cancer was responding to their combined chemotherapy and immunotherapy treatment. The goal was to see if this scan could detect treatment success or failure earlier than the standard MRI or CT scans. The study was designed for patients with stage I-IV triple-negative breast cancer who were starting this specific treatment plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Penn State Health College of Medicine
Hershey, Pennsylvania, 17033, United States
Conditions
Explore the condition pages connected to this study.